Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (567)	12/21/1999 8:54:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 626

TD, Bio world article on CeaVac. Before getting there, I am not sure if this was posted before: jco.org link to full-text version of Foon's CeaVac report in JCO. Some of the Bioworld statements seem to come from the study reported there. OK, the article, I think you got 99% of the meat from investorMD already. Let's see what else of interest ... OK Bucalo says that their business model calls for partnering of this late-stage development project. And the co-inventor, with Foon, of CeaVac is Malaya Chatterjee. Previously, I had put this in the PB web page (have forgotten to link it from the main one, oh well): geocities.com PB